An undisclosed buyer agreed to acquire 8.6% stake in Hanchang Biotech Co., Ltd. (KOSDAQ:A043090) from Hanchang Corporation (KOSE:A005110) for KRW 6.8 billion on August 3, 2022. Post completion, Hanchang Corporation will hold 5.47% stake in Hanchang Biotech. Board resolution date (decision date) was August 3, 2022.

Expected date of sale shall be September 15, 2022.